|
LOC641298 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.163400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.230400E-01 |
| Normal-vs-Stage2 |
9.153000E-01 |
| Normal-vs-Stage3 |
4.869600E-01 |
| Normal-vs-Stage4 |
6.656200E-01 |
| Stage1-vs-Stage2 |
4.277600E-01 |
| Stage1-vs-Stage3 |
1.019410E-01 |
| Stage1-vs-Stage4 |
9.638000E-01 |
| Stage2-vs-Stage3 |
6.167200E-01 |
| Stage2-vs-Stage4 |
6.482200E-01 |
| Stage3-vs-Stage4 |
3.970600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.845600E-01 |
| Normal-vs-AfricanAmerican |
8.916400E-01 |
| Normal-vs-Asian |
4.655900E-03 |
| Caucasian-vs-AfricanAmerican |
9.864800E-01 |
| Caucasian-vs-Asian |
7.829500E-04 |
| AfricanAmerican-vs-Asian |
1.163960E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.669400E-01 |
| Normal-vs-Female |
2.987600E-01 |
| Male-vs-Female |
3.597600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.468200E-01 |
| Normal-vs-Extreme_Weight |
2.703200E-01 |
| Normal-vs-Obese |
6.533400E-01 |
| Normal-vs-Extreme_Obese |
7.143600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.203400E-01 |
| Normal_Weight-vs-Obese |
2.207200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.698800E-01 |
| Extreme_Weight-vs-Obese |
4.737800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.474600E-01 |
| Obese-vs-Extreme_Obese |
4.900000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.080600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.768400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.159600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.260980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.533030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.868600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.131000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.896100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.192100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.495800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.638000E-01 |
| Normal-VS-Type2 PRCC |
4.101200E-01 |
| Normal-VS-KIRP CIMP |
5.655800E-01 |
| Normal-VS-Unclassified PRCC |
2.190800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.842400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.604200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.624560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.550600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.314200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.673800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.265600E-01 |
| Normal-vs-N1 |
4.775600E-01 |
| Normal-vs-N2 |
6.651400E-01 |
| N0-vs-N1 |
2.016000E-01 |
| N0-vs-N2 |
5.024200E-01 |
| N1-vs-N2 |
9.593000E-01 |
|
|
